view high-bandwidth site

Other Infectious Disease

Current and past Wave 80 development programs encompass wide-ranging sample preparation processes and assays for a range of infectious diseases—with both molecular and non-molecular targets.

  • EOSCAPE-STD.
    Quantitative assay detecting chlamydia and gonorrhea in vaginal swabs.
  • Hepatitis B.
    Quantitative assay measuring HBV DNA in circulating blood.
  • Tuberculosis.
    Quantitative assay measuring TB bacterial DNA/RNA in sputum.
  • Tuberculosis-DST.
    Qualitative assay for identifying resistance to rifampicin and fluoroquinolone from sputum. For use in a reflex testing model with conventional TB diagnostics.
  • Hepatitis C.
    Qualitative assay detecting presence of each of the six major HCV genotypes in whole blood.